Korean Air has been awarded the IATA Center of
Excellence for Independent Validators (CEIV) Pharma certification.
IATA's 'CEIV Pharma' is an international standard that indicates
an airline’s capability to manage pharmaceuticals, including the
handling procedure, equipment and facilities. More than 280 check
lists are evaluated by validator to authorize the certification.
The pharmaceutical product is a booming cargo sector,
with an annual average growth rate of 5.4% over the past decade.
Unlike general cargo, pharmaceuticals such as vaccines or insulin,
can be easily spoiled unless transported at the correct
temperature or refrigerated storage. In this respect, Korean Air
has established a strict management system to control
temperatures.
Korean Air has set up implementing
procedures to deal with various situations such as power failure
or temperature changes when opening and closing the
temperature-controlled facilities of the cargo terminal.
In preparation for the ‘CEIV Pharma’ certification, Korean
Air adopted the international standard and regulations for
handling pharmaceuticals and established high quality customized
services. Korean Air also conducted special pharmaceutical
training for all employees, including its suppliers.
In total, 220 companies, including 18 airlines, have received the
‘CEIV Pharma’ certification thus far.
Headlines: |
|
See latest
HD Video
Interviews,
Podcasts
and other
news regarding:
Korean Air,
Pharmaceutical,
Pharma,
CEIV.
|